- $3.27bn
- $2.44bn
- $218.71m
U.S. STOCKS ON THE MOVE-Glaukos, Reddit, Micron
U.S. STOCKS ON THE MOVE-Boeing, Planet Labs, WW International
Ideaya rises as drug combo shows survival benefit in rare eye cancer trial
Brief: IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
U.S. STOCKS ON THE MOVE-Sanofi SA, Nutanix, Bullish
U.S. STOCKS ON THE MOVE-New Fortress Energy, Pulse Biosciences, US telecom stocks
Brief: IDEAYA Reports Positive Phase 1/2 Data for IDE397 + Trodelvy in MTAP-Deleted Urothelial Cancer
U.S. STOCKS ON THE MOVE-Veeva, Gold miners, Ideaya Biosciences
Ideaya Biosciences gains on mid-stage data for eye cancer drug
U.S. RESEARCH ROUNDUP-Alphabet, Copart, Leidos
Brief: Ideaya Biosciences Inc - Servier And Ideaya Enter Exclusive License For Darovasertib Outside Us
U.S. RESEARCH ROUNDUP-Allstate, BP, Oracle
Ideaya Biosciences Inc Reports Results For The Quarter Ended June 30: Earnings Summary
IDEAYA Biosciences's Q2 net loss widens as costs mount
Brief: Ideaya Biosciences Announces Inducement Grants Under Nasdaq Listing Rule
U.S. RESEARCH ROUNDUP-Penumbra, UnitedHealth, Visa
Brief: Ideaya Biosciences Announces Inducement Grants Under Nasdaq Listing Rule
Ideaya Biosciences Inc Reports Results For The Quarter Ended March 31: Earnings Summary
Brief: IDEAYA Biosciences Announces US FDA IND-Clearance For IDE849, A Potential First-In-Class DLL3 TOP1 ADC, For A Phase 1 Study In Solid Tumors